Patents by Inventor Justin Monnier

Justin Monnier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of enhancing anti-tumor immunity by administering antibodies to the CCRL2 chemerin receptor
    Patent number: 9868792
    Abstract: Chemerin is a chemoattractant that selectively directs intra-tumor recruitment of CMKLR1+ cells. Blockade of CCRL2 from binding to chemerin in non-neoplastic tumor cells, e.g. peri-tumor stromal and/or hematopoietic cells allows for redistribution of chemerin into the tumor and enhanced responsiveness against a tumor.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: January 16, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Brian A. Zabel, Eugene C. Butcher, Russell K. Pachynski, Justin Monnier
  • MOBILIZING ANTI-TUMOR IMMUNITY BY TARGETING CHEMERIN RECEPTOR CCRL2
    Publication number: 20170002087
    Abstract: Chemerin is a chemoattractant that selectively directs intra-tumor recruitment of CMKLR1+ cells. Blockade of CCRL2 from binding to chemerin in non-neoplastic tumor cells, e.g. peri-tumor stromal and/or hematopoietic cells allows for redistribution of chemerin into the tumor and enhanced responsiveness against a tumor.
    Type: Application
    Filed: June 30, 2016
    Publication date: January 5, 2017
    Inventors: Brian A. Zabel, Eugene C. Butcher, Russell K. Pachynski, Justin Monnier